Platinum Investment Management LTD Cogent Biosciences, Inc. Transaction History

Platinum Investment Management LTD

$1.43 Billion
Q3 2025

A detailed history of Platinum Investment Management LTD transactions in Cogent Biosciences, Inc. stock. As of the latest transaction made, Platinum Investment Management LTD holds 219,504 shares of COGT stock, worth $7.36 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

219,504

Previous 219,504 -0.0%

Holding current value

$7.36 Million

Previous $1.58 Million 100.0%

% of portfolio

0.22%

Previous 0.11%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 18, 2025	BUY	$4.02 - $7.51 $344,087 - $642,810	85,594 Added 63.92%	219,504 $1.58 Million
Q1 2025 May 15, 2025	SELL	$5.99 - $9.66 $143,406 - $231,270	-23,941 Reduced 15.17%	133,910 $802,000
Q2 2024 Aug 12, 2024	SELL	$6.01 - $9.04 $170,702 - $256,763	-28,403 Reduced 15.25%	157,851 $1.33 Million
Q1 2024 May 13, 2024	SELL	$4.38 - $9.02 $1.27 Million - $2.61 Million	-289,380 Reduced 60.84%	186,254 $1.25 Million
Q4 2023 Feb 13, 2024	SELL	$4.06 - $10.08 $824 - $2,046	-203 Reduced 0.04%	475,634 $2.8 Million

Q3 2023 Nov 02, 2023	SELL	$9.69 - $13.34 $12,044 - $16,581	-1,243 Reduced 0.26%	475,837 $4.64 Million
Q1 2023 May 11, 2023	SELL	$10.04 - $15.5 $344,472 - $531,805	-34,310 Reduced 6.71%	477,080 $5.15 Million
Q3 2022 Nov 14, 2022	SELL	$9.39 - $16.99 $3.66 Million - $6.63 Million	-390,022 Reduced 43.27%	511,390 $7.63 Million
Q2 2022 Aug 11, 2022	SELL	$3.92 - $9.73 $585,205 - $1.45 Million	-149,287 Reduced 14.21%	901,412 $8.13 Million
Q4 2021 Feb 11, 2022	BUY	$7.51 - $10.81 $513,691 - $739,414	68,401 Added 6.96%	1,050,699 $9.02 Million
Q3 2021 Nov 09, 2021	BUY	$5.99 - $9.14 $935,512 - $1.43 Million	156,179 Added 18.91%	982,298 $8.26 Million
Q2 2021 Aug 11, 2021	BUY	$7.82 - $9.3 $736,769 - $876,208	94,216 Added 12.87%	826,119 $6.7 Million
Q1 2021 May 13, 2021	BUY	$7.47 - $12.34 $1.91 Million - $3.16 Million	256,198 Added 53.86%	731,903 $6.43 Million
Q4 2020 Feb 12, 2021	BUY	$9.04 - $13.01 $4.3 Million - $6.19 Million	475,705 New	475,705 $5.34 Million

Others Institutions Holding COGT

# of Institutions

215

Shares Held

133M

Call Options Held

999K

Put Options Held

429K

View Full List

About Cogent Biosciences, Inc.

Ticker COGT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,758,300
Market Cap $2.21B
Description
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...

More about COGT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Platinum Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Platinum Investment Management LTD with notifications on news.

Account

Platinum Investment Management LTD Cogent Biosciences, Inc. Transaction History